Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004587791 | SCV005076805 | pathogenic | Wiskott-Aldrich syndrome | 2024-04-09 | criteria provided, single submitter | clinical testing | Variant summary: WAS c.984delG (p.Pro330LeufsX115) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant was absent in 150189 control chromosomes (gnomAD). c.984delG has been reported in the literature in at least one individual affected with Wiskott-Aldrich Syndrome (Lutskiy_2005). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 16002738). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as pathogenic. |